Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Esteban

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Gates Open Research|April 21, 2022
Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progressionIgnacio Esteban, Georgina Bergero, Camila Alves, et al.
International Archives of Allergy and Immunology|April 14, 2022
Serodominance Profile in a Dust Mite Complex RegionRaquel López-Rodríguez, Manuel Jorge Rial, Ignacio Esteban-Gorgojo, et al.
Journal of Virology|November 25, 2005
Effect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infectionJosep Quer, Juan Ignacio Esteban, Joan Cos, et al.
Annals of Hepatology|January 5, 2017
Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplantLluís Castells, Jordi Llaneras, Isabel Campos-Varela, et al.
Hepatology Communications|November 19, 2021
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control StudyTeerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, et al.
Infection and Drug Resistance|October 2, 2019
Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatmentFatma Amer, Monkez M Yousif, Noha M Hammad, et al.
Annals of Hepatology|February 21, 2014
Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipientsIsabel Campos-Varela, Juan Ignacio Esteban, Marta Bes, et al.
Journal of Virology|August 15, 2014
Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virusJulie Sheldon, Nathan M Beach, Elena Moreno, et al.
Hepatology (Baltimore, Md.)|April 1, 2011
Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cellsItziar Echeverria, Alexander Pereboev, Leyre Silva, et al.
Virus Research|January 2, 2017
Deep sequencing in the management of hepatitis virus infectionsJosep Quer, Francisco Rodríguez-Frias, Josep Gregori, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Gates Open Research|April 21, 2022
Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progressionIgnacio Esteban, Georgina Bergero, Camila Alves, et al.
International Archives of Allergy and Immunology|April 14, 2022
Serodominance Profile in a Dust Mite Complex RegionRaquel López-Rodríguez, Manuel Jorge Rial, Ignacio Esteban-Gorgojo, et al.
Journal of Virology|November 25, 2005
Effect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infectionJosep Quer, Juan Ignacio Esteban, Joan Cos, et al.
Annals of Hepatology|January 5, 2017
Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplantLluís Castells, Jordi Llaneras, Isabel Campos-Varela, et al.
Hepatology Communications|November 19, 2021
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control StudyTeerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, et al.
Infection and Drug Resistance|October 2, 2019
Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatmentFatma Amer, Monkez M Yousif, Noha M Hammad, et al.
Annals of Hepatology|February 21, 2014
Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipientsIsabel Campos-Varela, Juan Ignacio Esteban, Marta Bes, et al.
Journal of Virology|August 15, 2014
Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virusJulie Sheldon, Nathan M Beach, Elena Moreno, et al.
Hepatology (Baltimore, Md.)|April 1, 2011
Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cellsItziar Echeverria, Alexander Pereboev, Leyre Silva, et al.
Virus Research|January 2, 2017
Deep sequencing in the management of hepatitis virus infectionsJosep Quer, Francisco Rodríguez-Frias, Josep Gregori, et al.
Pageof 11